Fig. 3From: The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort studyComparison between the NAC-PWL < 5% group and the NAC-PWL ≥ 5% group for A disease-free survival, B overall survival, C distant metastasis-free survival, and D locoregional relapse-free survival. NAC-PWL: percentage of weight loss during neoadjuvant chemotherapy (NAC)Back to article page